MarketsNotableConfirmed
9.4
Johnson & Johnson raises FY2026 guidance following Q2 earnings beat
Valor Econômico·US·3 days ago
Researchers have identified a novel mechanism for regulating inflammation, a critical factor in both cancer progression and immune response to infections. While the specific molecular pathway remains to be detailed in peer-reviewed literature, the discovery offers a potential new target for therapeutic intervention in chronic inflammatory conditions.